Results 61 to 70 of about 2,807 (168)
The Application of PD‐1 Inhibitors in Immunotherapy for Glioblastoma
The molecular mechanism of PD‐1. When PD‐1 binds to PD‐L1, the ITIM and ITSM domains within PD‐1 are phosphorylated and subsequently recruit SHP‐2. This then dephosphorylates downstream molecules of the TCR, such as PI3K/AKT and ZAP70, reduces the secretion of IFN‐γ, and inhibits the presentation of antigens to T cells via MHC molecules through the ...
Ming‐zhen Dong +4 more
wiley +1 more source
Ethnic and Gender Disparities in Access to Deep Brain Stimulation Surgery for Parkinson's Disease
Abstract Background Deep brain stimulation (DBS) is an established treatment for Parkinson's disease (PD) in appropriately selected patients. DBS may be underused in certain patient populations, especially women and racialized groups. Barriers and biases to receiving DBS that could account for underuse among these groups are not well studied in Canada.
Fang Ba +14 more
wiley +1 more source
Abstract Purpose To develop a knowledge‐based deep model for sCT generation from a single MR volume in LINAC‐based frameless SRS, enabling the MR‐only workflow without extra CT simulation. Methods A total of 139 patients were included in the study, with 120 used for training and 19 for testing.
Xiwen Shu +8 more
wiley +1 more source
RapidArc dynamic versus RapidArc: A multi anatomical‐site dosimetric evaluation
Abstract Background RapidArc (RA) has advanced VMAT delivery; however, challenges remain in achieving optimal organ‐at‐risk (OAR) sparing in complex cases. RapidArc Dynamic (RAD), a next‐generation Volumetric Modulation Arc Therapy (VMAT) technique, incorporates dynamic collimator rotation, embedded static fields, and a faster optimizer to enhance dose
Aram Rostami +13 more
wiley +1 more source
Background: Although whole-brain radiotherapy (WBRT) has been the standard treatment for brain metastases, its cognitive side effects have led to the rise of stereotactic radiosurgery (SRS), which offers better local control with less neurocognitive ...
Poopalan Sivakumar +4 more
doaj +1 more source
Sinonasal Sarcomas Management: An International Consensus Statement
ABSTRACT Introduction Sinonasal sarcomas are exceedingly rare entities, constituting less than 7% of head and neck sarcomas. Their complex histology needs specialized treatment, which is often based on multimodal approaches including surgery, radiation therapy, and/or chemotherapy.
Alessandro Vinciguerra +51 more
wiley +1 more source
A Systematic Review of the Parkinson's Foundation Hospital Care Recommendations
Abstract Background People with Parkinson's disease (PwP) face increased risks of complications and longer hospital stays compared to the general population. Four major factors contribute to increased morbidity and mortality during hospitalization: medication timing errors, administration of harmful medications, restricted mobility, and dysphagia ...
Ariane Veilleux Carpentier +12 more
wiley +1 more source
Long-term outcomes with reduced-dose whole-brain radiotherapy and a stereotactic radiosurgery boost for primary central nervous system lymphoma. [PDF]
Foreman BE +8 more
europepmc +1 more source
Intensity-modulated radiotherapy with planned Gamma Knife radiosurgery boost for head and neck cancer with extensive disease in proximity to critical structures. [PDF]
Farris JC +16 more
europepmc +1 more source
Introduction: Although stereotactic ablative radiotherapy (SABR) has advance to standard-of-care for many different indications like lung and liver malignancies, it still remains in its infancy for treating head and neck cancer.
Ciro Franzese, Panagiotis Balermpas
doaj +1 more source

